Cambridge Cognition Holdings PLC

First-pass take

Profitable healthcare IT company with 37% revenue growth, strong gross margins (86%), and controlled cost growth demonstrating emerging operating leverage. However, no AI strategy or beneficiary exposure evident. Valuation data absent from filing. Pharma customer base exposure to discretionary spending and lack of detailed competitive moat limit appeal.